Literature DB >> 9795165

Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia.

R N Kalaria1, D L Cohen, D R Premkumar, S Nag, J C LaManna, W D Lust.   

Abstract

Several growth factors have been implicated in the pathogenesis of Alzheimer's disease (AD). We considered whether the vascular endothelial growth factor (VEGF) is involved in the vascular pathology associated with most cases of AD. We observed enhanced VEGF immunoreactivity in clusters of reactive astrocytes in the neocortex of subjects with AD compared to elderly controls. VEGF reactivity was also noted in walls of many large intraparenchymal vessels and diffuse perivascular deposits. In addition, we established that astrocytic and perivascular VEGF reactivity was enhanced in cerebral cortex of rats subjected to cerebral ischemia and to chronic hypoxia; experimental conditions known to be associated with astrogliosis and angiogenesis. We suggest the increased VEGF reactivity, also observed in infarcted human brain tissue, implicates compensatory mechanisms to counter insufficient vascularity or reduced perfusion (oligemia) apparent in AD. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795165     DOI: 10.1016/s0169-328x(98)00190-9

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  49 in total

1.  Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Authors:  Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

2.  Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.

Authors:  Daniel Paris; Nowel Ganey; Magdalena Banasiak; Vincent Laporte; Nikunj Patel; Myles Mullan; Susan F Murphy; Gi-Taek Yee; Corbin Bachmeier; Christopher Ganey; David Beaulieu-Abdelahad; Venkatarajan S Mathura; Steven Brem; Michael Mullan
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

3.  Multiple neurotrophic effects of VEGF on cultured neurons.

Authors:  Alma Sanchez; Suchin Wadhwani; Paula Grammas
Journal:  Neuropeptides       Date:  2010-04-28       Impact factor: 3.286

Review 4.  Microglial interactions with the neurovascular system in physiology and pathology.

Authors:  Xiaoliang Zhao; Ukpong B Eyo; Madhuvika Murugan; Long-Jun Wu
Journal:  Dev Neurobiol       Date:  2018-02-01       Impact factor: 3.964

Review 5.  Vascular basis for brain degeneration: faltering controls and risk factors for dementia.

Authors:  Raj N Kalaria
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

6.  Evidence of angiogenic vessels in Alzheimer's disease.

Authors:  Brinda S Desai; Julie A Schneider; Jia-Liang Li; Paul M Carvey; Bill Hendey
Journal:  J Neural Transm (Vienna)       Date:  2009-04-16       Impact factor: 3.575

7.  No association of VEGF polymorphims with Alzheimer's disease.

Authors:  Sara Landgren; Mona Seibt Palmér; Ingemar Skoog; Lennart Minthon; Anders Wallin; Niels Andreasen; Madeleine Zetterberg; Kaj Blennow; Henrik Zetterberg
Journal:  Neuromolecular Med       Date:  2009-10-20       Impact factor: 3.843

8.  Microglial chemotactic signaling factors in Alzheimer's disease.

Authors:  James G McLarnon
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 9.  Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.

Authors:  Fan Su; Feng Bai; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2016-08-27       Impact factor: 5.203

10.  New applications of nanotechnology for neuroimaging.

Authors:  G Suffredini; J E East; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-28       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.